Another recent report demonstrated a tumor suppressive function of miR-642a in liver cancer (hepatocellular carcinoma (HCC)); miR-642a expression was decreased, which enabled increased SEMA4C expression and signaling via the p38 MAPK pathway40. The gene discussed is SEMA4C; the disease is liver cancer.